NO20060202L - Pyrrolodihydroisokinoliner som PDE-10-inhibitorer - Google Patents
Pyrrolodihydroisokinoliner som PDE-10-inhibitorerInfo
- Publication number
- NO20060202L NO20060202L NO20060202A NO20060202A NO20060202L NO 20060202 L NO20060202 L NO 20060202L NO 20060202 A NO20060202 A NO 20060202A NO 20060202 A NO20060202 A NO 20060202A NO 20060202 L NO20060202 L NO 20060202L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- pyrrolodihydroisoquinolines
- pde
- pdeio
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03014424 | 2003-06-30 | ||
| PCT/EP2004/051307 WO2005003129A1 (en) | 2003-06-30 | 2004-06-30 | Pyrrolodihydroisoquinolines as pde10 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060202L true NO20060202L (no) | 2006-01-13 |
Family
ID=33560746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060202A NO20060202L (no) | 2003-06-30 | 2006-01-13 | Pyrrolodihydroisokinoliner som PDE-10-inhibitorer |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20060148840A1 (sr) |
| EP (2) | EP1641792B1 (sr) |
| JP (2) | JP2009513495A (sr) |
| KR (1) | KR20060030483A (sr) |
| CN (2) | CN1809565A (sr) |
| AR (2) | AR044956A1 (sr) |
| AT (1) | ATE478868T1 (sr) |
| AU (2) | AU2004253694A1 (sr) |
| BR (1) | BRPI0411897A (sr) |
| CA (2) | CA2530316A1 (sr) |
| DE (1) | DE602004028827D1 (sr) |
| EA (1) | EA012110B1 (sr) |
| IL (1) | IL171997A0 (sr) |
| IS (1) | IS8238A (sr) |
| MX (2) | MXPA05013822A (sr) |
| NO (1) | NO20060202L (sr) |
| NZ (1) | NZ544591A (sr) |
| RS (2) | RS20050945A (sr) |
| TW (2) | TW200510407A (sr) |
| UA (1) | UA86591C2 (sr) |
| WO (2) | WO2005003130A1 (sr) |
| ZA (2) | ZA200509265B (sr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004253694A1 (en) * | 2003-06-30 | 2005-01-13 | 4Sc Ag | Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| AU2006205797A1 (en) * | 2005-01-12 | 2006-07-20 | 4Sc Ag | Pyrrolodihydroisoquinolines as antiproliferative agents |
| US20080161338A1 (en) * | 2005-01-12 | 2008-07-03 | Altana Pharma Ag | Novel Pyrrolodihydroisoquinolines as Pde 10 Inhibitors |
| JP2010502670A (ja) | 2006-09-07 | 2010-01-28 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 真性糖尿病のための組合せ治療 |
| MX2009013354A (es) | 2007-06-04 | 2010-07-06 | Univ Ben Gurion | Compuestos de triarilo y composiciones que los contienen. |
| TW200918519A (en) * | 2007-09-19 | 2009-05-01 | Lundbeck & Co As H | Cyanoisoquinoline |
| US7858620B2 (en) | 2007-09-19 | 2010-12-28 | H. Lundbeck A/S | Cyanoisoquinoline |
| TW200944523A (en) | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
| MX2010009300A (es) | 2008-02-29 | 2010-11-05 | Concert Pharmaceuticals Inc | Derivados de xantina substituidos. |
| UA102693C2 (ru) | 2008-06-20 | 2013-08-12 | Х. Луннбек А/С | Производные фенилимидазола как ингибиторы фермента pde10a |
| TWI501965B (zh) * | 2008-06-20 | 2015-10-01 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物 |
| US8133897B2 (en) | 2008-06-20 | 2012-03-13 | H. Lundbeck A/S | Phenylimidazole derivatives as PDE10A enzyme inhibitors |
| US20110053961A1 (en) | 2009-02-27 | 2011-03-03 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
| TWI461426B (zh) * | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | （二氫）咪唑並異〔５，１－ａ〕喹啉類 |
| TWI485151B (zh) | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| TWI481607B (zh) | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物 |
| TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物 |
| TW201200516A (en) | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
| TW201215607A (en) | 2010-07-02 | 2012-04-16 | Lundbeck & Co As H | Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor |
| TW201206935A (en) | 2010-07-16 | 2012-02-16 | Lundbeck & Co As H | Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor |
| DE102010042833B4 (de) | 2010-10-22 | 2018-11-08 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung |
| JO3089B1 (ar) | 2010-11-19 | 2017-03-15 | H Lundbeck As | مشتقات ايميدازول كمثبطات لانزيمات pde10a |
| JP2014510055A (ja) | 2011-02-18 | 2014-04-24 | アラーガン インコーポレイテッド | ホスホジエステラーゼ１０（ｐｄｅ１０ａ）阻害剤としての置換６，７−ジアルコキシ−３−イソキノリノール誘導体 |
| WO2013013052A1 (en) | 2011-07-19 | 2013-01-24 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
| WO2013045607A1 (en) | 2011-09-30 | 2013-04-04 | H. Lundbeck A/S | Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
| WO2013050527A1 (en) | 2011-10-05 | 2013-04-11 | H. Lundbeck A/S | Quinazoline derivatives as pde10a enzyme inhibitors |
| AR089361A1 (es) | 2011-12-21 | 2014-08-20 | Lundbeck & Co As H | Derivados de quinolina como inhibidores de la enzima pde10a |
| WO2013127817A1 (en) | 2012-02-27 | 2013-09-06 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
| WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| CN103059029B (zh) * | 2012-12-28 | 2014-12-10 | 塔里木大学 | 一种六氢吡咯[2,3]并吲哚类化合物及其制备方法和在杀菌活性中的应用 |
| LT3027613T (lt) * | 2013-07-25 | 2018-07-25 | Uniwersytet Jagiellonski | Pirolochinolino dariniai kaip 5-ht6 antagonistai, jų gavimas ir panaudojimas |
| CA2928725A1 (en) | 2013-11-05 | 2015-05-14 | Esther Priel | Compounds for the treatment of diabetes and disease complications arising from same |
| US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
| CA2981791A1 (en) | 2014-04-18 | 2015-10-22 | Concert Pharmaceuticals, Inc. | Methods of treating hyperglycemia |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE690792A (sr) * | 1966-12-07 | 1967-05-16 | ||
| DE3401018A1 (de) * | 1984-01-13 | 1985-07-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen |
| FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1347973A1 (en) * | 2000-12-13 | 2003-10-01 | Bayer Aktiengesellschaft | Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| US20030018047A1 (en) * | 2001-04-20 | 2003-01-23 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| US20030032579A1 (en) * | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| IL149106A0 (en) * | 2001-04-20 | 2002-11-10 | Pfizer Prod Inc | Therapeutic use of selective pde10 inhibitors |
| DE10130151A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Neue Verwendung für PDE 10A-Inhibitoren |
| WO2003014116A1 (en) * | 2001-08-06 | 2003-02-20 | Bayer Corporation | Pyrrolo[2.1-a]isoquinoline derivatives |
| WO2003014115A1 (en) * | 2001-08-06 | 2003-02-20 | Bayer Aktiengesellschaft | 3-substituted pyrrolo (2.1-a) isoquinoline derivatives |
| AU2002366362A1 (en) * | 2001-12-18 | 2003-06-30 | Bayer Aktiengesellschaft | 2-substituted pyrrolo(2.1-a)isoquinolines against cancer |
| AU2004253694A1 (en) * | 2003-06-30 | 2005-01-13 | 4Sc Ag | Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| AU2006205797A1 (en) * | 2005-01-12 | 2006-07-20 | 4Sc Ag | Pyrrolodihydroisoquinolines as antiproliferative agents |
| US20080161338A1 (en) * | 2005-01-12 | 2008-07-03 | Altana Pharma Ag | Novel Pyrrolodihydroisoquinolines as Pde 10 Inhibitors |
-
2004
- 2004-06-30 AU AU2004253694A patent/AU2004253694A1/en not_active Abandoned
- 2004-06-30 NZ NZ544591A patent/NZ544591A/xx unknown
- 2004-06-30 TW TW093119589A patent/TW200510407A/zh unknown
- 2004-06-30 AR ARP040102290A patent/AR044956A1/es not_active Application Discontinuation
- 2004-06-30 EP EP04741932A patent/EP1641792B1/en active Active
- 2004-06-30 CN CNA2004800175231A patent/CN1809565A/zh active Pending
- 2004-06-30 US US10/562,137 patent/US20060148840A1/en not_active Abandoned
- 2004-06-30 AU AU2004253690A patent/AU2004253690B2/en not_active Ceased
- 2004-06-30 WO PCT/EP2004/051315 patent/WO2005003130A1/en active Application Filing
- 2004-06-30 EP EP04766106A patent/EP1641794A1/en not_active Withdrawn
- 2004-06-30 AR ARP040102291A patent/AR045696A1/es not_active Application Discontinuation
- 2004-06-30 US US10/562,149 patent/US20060148838A1/en not_active Abandoned
- 2004-06-30 BR BRPI0411897-9A patent/BRPI0411897A/pt not_active IP Right Cessation
- 2004-06-30 JP JP2006516198A patent/JP2009513495A/ja active Pending
- 2004-06-30 RS YUP-2005/0945A patent/RS20050945A/sr unknown
- 2004-06-30 UA UAA200600505A patent/UA86591C2/ru unknown
- 2004-06-30 AT AT04741932T patent/ATE478868T1/de not_active IP Right Cessation
- 2004-06-30 CA CA002530316A patent/CA2530316A1/en not_active Abandoned
- 2004-06-30 TW TW093119579A patent/TW200510413A/zh unknown
- 2004-06-30 CA CA002530317A patent/CA2530317A1/en not_active Abandoned
- 2004-06-30 JP JP2006516197A patent/JP2009513494A/ja active Pending
- 2004-06-30 WO PCT/EP2004/051307 patent/WO2005003129A1/en active Application Filing
- 2004-06-30 DE DE602004028827T patent/DE602004028827D1/de active Active
- 2004-06-30 CN CNA2004800175104A patent/CN1809564A/zh active Pending
- 2004-06-30 RS YUP-2005/0946A patent/RS20050946A/sr unknown
- 2004-06-30 KR KR1020057024872A patent/KR20060030483A/ko not_active Application Discontinuation
- 2004-06-30 MX MXPA05013822A patent/MXPA05013822A/es unknown
- 2004-06-30 MX MXPA05013553A patent/MXPA05013553A/es active IP Right Grant
- 2004-06-30 EA EA200501928A patent/EA012110B1/ru not_active IP Right Cessation
-
2005
- 2005-11-16 ZA ZA200509265A patent/ZA200509265B/en unknown
- 2005-11-16 ZA ZA200509267A patent/ZA200509267B/en unknown
- 2005-11-16 IL IL171997A patent/IL171997A0/en unknown
-
2006
- 2006-01-13 NO NO20060202A patent/NO20060202L/no not_active Application Discontinuation
- 2006-01-18 IS IS8238A patent/IS8238A/is unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060202L (no) | Pyrrolodihydroisokinoliner som PDE-10-inhibitorer | |
| DK1682530T3 (da) | Pyrrolsubstituerede indoler som inhibitorer af PAI-1 | |
| BR0313330A (pt) | Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4 | |
| DE602004006618D1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
| CY1110064T1 (el) | Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης | |
| NO20081636L (no) | FAP - inhibitorer | |
| DK1483265T3 (da) | Purinderivater som kinaseinhibitorer | |
| EA200800321A1 (ru) | Ингибиторы гистондеацетилазы | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| ATE548374T1 (de) | 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren | |
| NO20092710L (no) | Cyclopaminanaloger | |
| DK1881967T3 (da) | Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
| NO20061317L (no) | Imidazopyridinderivater som induserbare NO-syntaseinhibatorer | |
| ATE510822T1 (de) | Kaliumkanalinhibitoren | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
| EA201270630A1 (ru) | Гетероциклические сетр ингибиторы | |
| EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
| EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| EA200800070A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина | |
| ATE542796T1 (de) | N-sulfonylcarboximidamidverbindungen als apoptosepromotoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |